trimetazidine has been researched along with Acute Coronary Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balan, A; Bobescu, E; Covaciu, A; Dima, L; Marceanu, LG; Strempel, CG | 1 |
| Banach, M; Goch, A; Mikhailidis, DP; Rosano, GM; Rysz, J | 1 |
| Barone, L; Crea, F; Di Monaco, A; Lamendola, P; Lanza, GA; Pisanello, C | 1 |
| Blanc-Guillemaud, V; Bui-Xuan, B; Bui-Xuan, C; Chevalier, P; Dehina, L; Descotes, J; Dizerens, N; Lerond, L; Tabib, A; Timour, Q; Vaillant, F | 1 |
2 review(s) available for trimetazidine and Acute Coronary Syndrome
| Article | Year |
|---|---|
The role of trimetazidine after acute myocardial infarction.
Topics: Acute Coronary Syndrome; Angina Pectoris; Cardiovascular Agents; Energy Metabolism; Humans; Myocardial Infarction; Myocardium; Practice Guidelines as Topic; Treatment Outcome; Trimetazidine | 2008 |
[Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
Topics: Acetanilides; Acute Coronary Syndrome; Angina Pectoris; Animals; Apoptosis; Cell Death; Collateral Circulation; Disease Models, Animal; Humans; Ischemic Preconditioning, Myocardial; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Oxygen Consumption; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Trimetazidine; Vasodilator Agents | 2009 |
2 other study(ies) available for trimetazidine and Acute Coronary Syndrome
| Article | Year |
|---|---|
Trimetazidine Therapy in Coronary Artery Disease: The Impact on Oxidative Stress, Inflammation, Endothelial Dysfunction, and Long-Term Prognosis.
Topics: Acute Coronary Syndrome; Coronary Artery Disease; Humans; Inflammation; Oxidative Stress; Prognosis; Prospective Studies; Trimetazidine | 2021 |
Trimetazidine demonstrated cardioprotective effects through mitochondrial pathway in a model of acute coronary ischemia.
Topics: Action Potentials; Acute Coronary Syndrome; Animals; Cardiotonic Agents; Delayed-Action Preparations; Disease Models, Animal; Drug Administration Schedule; Heart Rate; Mitochondria, Heart; Reactive Oxygen Species; Swine; Trimetazidine; Ventricular Fibrillation | 2013 |